The University of Chicago Header Logo

Michael Macklin

TitleAssistant Professor
InstitutionUniversity of Chicago
DepartmentMedicine-Rheumatology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Michael Macklin is a faculty member of the Section of Rheumatology at the University of Chicago, an expert in the care of patients with systemic sclerosis (scleroderma) and interstitial lung diseases (ILD). Dr. Michael Macklin is the director of the multidisciplinary Scleroderma Program at the University of Chicago, encompassing specialists in Pulmonary, Cardiology, Gastroenterology, Plastic Surgery, and Dermatology, who provide comprehensive care to individuals carrying the diagnosis of systemic sclerosis (scleroderma).He has worked on projects devoted to improving the diagnosis and treatment of individuals of systemic sclerosis. His clinical research has focused on clinical trials for patients with systemic sclerosis, including cell therapy such as CAR-T cells.
    Dr. Michael Macklin is also a member of the multidisciplinary interstitial lung disease (ILD) group at the University of Chicago and hosts a combined rheumatology-pulmonary clinic dedicated to patients with ILD due to autoimmune diseases. The ILD Program at the University of Chicago has been internationally recognized for its innovative and collaborative clinical research in ILD and also provides clinical trials for these diseases.
    Dr. Michael Macklin also has an interest in IgG4 related disease and is a member of the multidisciplinary IgG4 Clinical Consortium at the University of Chicago, encompassing specialists from Gastroenterology, Pathology, Nephrology, Ophthalmology and Neurology.
    Dr. Michael Macklin also is very interested in medical education and works with learners at all stages in their medical training.

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Macklin M, Thompson C, Kawano-Dourado L, Bauer Ventura I, Weschenfelder C, Trostchansky A, Marcadenti A, Tighe RM. Linking Adiposity to Interstitial Lung Disease: The Role of the Dysfunctional Adipocyte and Inflammation. Cells. 2023 09 05; 12(18). PMID: 37759429; PMCID: PMC10526202.
      Citations: 3     Fields:    Translation:HumansCells
    2. Macklin M, Yadav S, Jan R, Reid P. Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics. Pharmaceuticals (Basel). 2023 Feb 08; 16(2). PMID: 37259404; PMCID: PMC9962184.
      Citations: 7     
    Macklin's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (6)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _